• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER Back to Search Results
Catalog Number SGC0302
Device Problem Difficult or Delayed Positioning (1157)
Patient Problems Low Blood Pressure/ Hypotension (1914); Perforation (2001)
Event Date 08/21/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Concomitant medical products: guide wire: 260cm extra stiff lundequist exchange guide wire, clip delivery system.The customer reported the device was discarded.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Event Description
This is filed to report the perforation.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with an mr grade of 4.The femoral vein was dilated and the steerable guide catheter (sgc) was inserted 10-20 cm; however, resistance was felt with the anatomy.The sgc was removed and the femoral vein was further dilated.The sgc was then advanced successfully.One clip was implanted, reducing mr to 1.When the sgc was removed, the patients blood pressure dropped to 60/30mmhg.An x-ray was used to screen the access site of the femoral vein and a perforation was noted on the proximal section of femoral vein prior to the ivc [inferior vena cava].Medication was given to treat the hypotension and a drug coated balloon was used to treat the perforation and control the bleeding.The blood pressure resolved after 20 minutes of monitoring.The patient was kept hospitalized for monitoring.It is the physician's opinion that the guide wire used to introduce the sgc was not suitable for the tortuous venous anatomy and that the sgc caused or contributed to the perforation.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.Additionally, a review of the complaint history identified no similar incidents reported from the lot.The reported patient effects of vessel perforation and hypotension as listed in the mitraclip system instructions for use are known possible complications associated with mitraclip procedures.All available information was investigated, and the difficult to advance (physical resistance) appears to be due to a combination of patient morphology/pathology (tortuous venous anatomy) and user technique/procedural conditions as the guide wire used to introduce the steerable guide catheter (sgc)was not suitable for the tortuous anatomy.The perforation appears to be a result of procedural circumstances of difficult sgc advancement, due to the patient anatomy and guide wire used to introduce the sgc.Hypotension was a cascading effect of the perforation.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
STEERABLE GUIDE CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
MENLO PARK, CA REG# 3005070406
abbott vascular
26531 ynez rd.
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key7869224
MDR Text Key119976342
Report Number2024168-2018-07103
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 11/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/24/2019
Device Catalogue NumberSGC0302
Device Lot Number80524U121
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/21/2018
Initial Date FDA Received09/12/2018
Supplement Dates Manufacturer Received10/30/2018
Supplement Dates FDA Received11/05/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/01/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-